Immune and Histopathological Biomarkers for Prognosis and Neoadjuvant Immunotherapy Response in Intrahepatic Cholangiocarcinoma
These findings provide critical insights for stratifying patients and highlight the potential for optimizing immune-targeted therapies in patients with iCCA.
Authors
- Tony Kiat Hon Lim (ORCID: https://orcid.org/0000-0003-0645-5164)
- Gaohua Wu (ORCID: https://orcid.org/0009-0002-7092-3284)
- Rongkui Luo (ORCID: https://orcid.org/0000-0002-4118-7225)
- Edwin Jun Chen Chew (ORCID: https://orcid.org/0000-0001-9728-3489)
- Qiang Gao (ORCID: https://orcid.org/0000-0002-9318-4501)
- Wei Qiang Leow (ORCID: https://orcid.org/0000-0001-6003-9837)
- Valerie Chew (ORCID: https://orcid.org/0000-0002-5617-0936)
- N. Jannah M. Nasir (ORCID: https://orcid.org/0000-0003-3700-9036)
- Ruoyu Shi (ORCID: https://orcid.org/0000-0001-8292-4044)
- Kai Zhu
Institutions
- Sun Yat-sen University (CN)
- Singapore General Hospital (SG)
- Fudan University (CN)
- SingHealth Duke-NUS Academic Medical Centre (SG)
- KK Women's and Children's Hospital (SG)
- Duke-NUS Medical School (SG)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Liver Cancer
- Published
- 2025-07-18
- DOI
- https://doi.org/10.1159/000547326
- Citations
- 2
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.01